24/7 Customer Support

+1 718 473 0872

The European Pharmaceutical Business

  • June 2012
  • 18 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

Refine your search results

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • October 2014
  • by GBI Research

Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development ...

Breast Cancer Diagnostic and Drug Technologies: Global Markets

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • $ 6 650
  • Industry report
  • Dec 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion ...


Related Market Segments :

Cancer
Lung Cancer
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.